BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND NR4A3, MINOR, 8013, ENSG00000119508, Q92570, CHN, NOR1, CSMF AND Prognosis
171 results:

  • 1. [Clinicopathological characteristics and immune microenvironment of breast squamous cell carcinoma].
    Liang JY; Wang YM; Wen Z; Zhang WH; Gao ZZ; Wang Z; Guo SP
    Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):337-343. PubMed ID: 38556816
    [No Abstract]    [Full Text] [Related]  

  • 2. Clinical outcomes and patient-reported outcomes after oncoplastic breast surgery in breast cancer patients: A matched cohort study.
    Chou HY; Tseng LM; Ma H; Perng CK; Huang CC; Tsai YF; Lin YS; Lien PJ; Feng CJ
    J Chin Med Assoc; 2024 Mar; 87(3):320-327. PubMed ID: 38252489
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. cancer stem cell-immune cell crosstalk in breast tumor microenvironment: a determinant of therapeutic facet.
    Guha A; Goswami KK; Sultana J; Ganguly N; Choudhury PR; Chakravarti M; Bhuniya A; Sarkar A; Bera S; Dhar S; Das J; Das T; Baral R; Bose A; Banerjee S
    Front Immunol; 2023; 14():1245421. PubMed ID: 38090567
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Analysis of B7-H4 Expression Across Salivary Gland Carcinomas Reveals Adenoid Cystic Carcinoma-Specific Prognostic Relevance.
    Siqueira JM; Mitani Y; Hoff CO; Bonini F; Guimaraes de Sousa L; Marques-Piubelli ML; Purushothaman A; Mitani M; Dai H; Lin SY; Spiotto MT; Hanna EY; McGrail DJ; El-Naggar AK; Ferrarotto R
    Mod Pathol; 2024 Jan; 37(1):100371. PubMed ID: 38015043
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The PD-1 single-nucleotide polymorphism rs11568821 and rs2227981 as a novel prognosis model in a triple-negative breast cancer patient.
    Boguszewska-Byczkiewicz K; Wow T; Szymańska B; Kosny M; Kolacinska-Wow A
    Mol Biol Rep; 2023 Jul; 50(7):6279-6285. PubMed ID: 37212960
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Influence of advanced age on the prognosis of triple-negative breast cancer patients: A surveillance, epidemiology, and end results-based study.
    Tan H; Fu D
    J Cancer Res Ther; 2023 Apr; 19(Supplement):S0. PubMed ID: 37147967
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. New findings on the action of hypericin in hypoxic cancer cells with a focus on the modulation of side population cells.
    Buľková V; Vargová J; Babinčák M; Jendželovský R; Zdráhal Z; Roudnický P; Košuth J; Fedoročko P
    Biomed Pharmacother; 2023 Jul; 163():114829. PubMed ID: 37146419
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Association of the Estrogen Receptor 1 Polymorphisms rs2046210 and rs9383590 with the Risk, Age at Onset and prognosis of breast cancer.
    Miedl H; Oswald D; Haslinger I; Gstoettner M; Wenzl R; Proestling K; Schneeberger C; Yotova I; Schreiber M
    Cells; 2023 Feb; 12(4):. PubMed ID: 36831182
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Association of the Telomerase Reverse Transcriptase rs10069690 Polymorphism with the Risk, Age at Onset and prognosis of Triple Negative breast cancer.
    Zins K; Peka E; Miedl H; Ecker S; Abraham D; Schreiber M
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768147
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Significance of the Estrogen Hormone and Single Nucleotide Polymorphisms in the Progression of breast cancer among Female.
    Mohammed Alwan A; Tavakol Afshari J; Afzaljavan F
    Arch Razi Inst; 2022 Jun; 77(3):943-958. PubMed ID: 36618302
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Association between the CASC16 rs4784227 polymorphism and breast cancer risk and prognosis in a northeast Chinese Han population.
    Zhang Y; Kou C; Jia L; Gao Y; Li X; Wu H; Chen N; Lv Z
    PeerJ; 2022; 10():e14462. PubMed ID: 36540803
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Overview of familial syndromes with increased skin malignancies.
    Juan HY; Zhou AE; Hoegler KM; Khachemoune A
    Arch Dermatol Res; 2023 May; 315(4):707-727. PubMed ID: 36342513
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Medical Data Analysis of CYP1B1 Gene Polymorphism and Clinical prognosis of Minimally Invasive Surgery for Lung cancer.
    Han X; Li D; Zhang S
    Biomed Res Int; 2022; 2022():5217625. PubMed ID: 36193313
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Single Nucleotide Variants in KIF14 Gene May Have Prognostic Value in breast cancer.
    Krus I; Brynychová V; Hlaváč V; Václavíková R; Kováčová M; Koževnikovová R; Kopečková K; Tornikidis J; Vrána D; Gatěk J; Souček P
    Mol Diagn Ther; 2022 Nov; 26(6):665-678. PubMed ID: 36192583
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Histocompatibility minor 13 (HM13), targeted by miR-760, exerts oncogenic role in breast cancer by suppressing autophagy and activating PI3K-AKT-mTOR pathway.
    Yang H; Li Z; Wang Z; Zhang X; Dai X; Zhou G; Ding Q
    Cell Death Dis; 2022 Sep; 13(8):728. PubMed ID: 36153332
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Secretory carcinoma of the salivary gland: a multi-institutional clinicopathologic study of 90 cases with emphasis on grading and prognostic factors.
    Xu B; Viswanathan K; Umrau K; Al-Ameri TAD; Dogan S; Magliocca K; Ghossein RA; Cipriani NA; Katabi N
    Histopathology; 2022 Nov; 81(5):670-679. PubMed ID: 35974431
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. BMPR1B Polymorphisms (rs1434536 and rs1970801) are Associated With breast cancer Susceptibility in Northwest Chinese Han Females: A Case-Control Study.
    Zheng Y; Jiang X; Wang M; Yang S; Deng Y; Li Y; Zhai Z; Wu Y; Wang N; Ren X; Kang H; Chen L
    Clin Breast Cancer; 2022 Jul; 22(5):e641-e646. PubMed ID: 35501253
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Estrogen Receptor Gene Polymorphism as a Possible Genetic Risk Factor for Treatment Response in ER-Positive breast cancer Patients.
    Allahloubi NMA; Zekri AN; Ragab M; Mohanad M; Ahmed OS; Eid S; Ghareeb M; Gouda I; Bahnassy AA
    Biochem Genet; 2022 Dec; 60(6):1963-1985. PubMed ID: 35182276
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Multimodal Treatment of Primary Advanced Ovarian cancer.
    Friedrich M; Friedrich D; Kraft C; Rogmans C
    Anticancer Res; 2021 Jul; 41(7):3253-3260. PubMed ID: 34230119
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Antiproliferative and antimetastatic characterization of an exo-heterocyclic androstane derivative against human breast cancer cell lines.
    Kulmány ÁE; Frank É; Kovács D; Kirisits K; Krupitza G; Neuperger P; Alföldi R; Puskás LG; Szebeni GJ; Zupkó I
    Biomed Pharmacother; 2021 Aug; 140():111728. PubMed ID: 34020244
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 9.